DRKS00015681招募中不适用
Sorin Universal REgistry on Aortic Valve Replacement - SURE-AVR
Sorin Group Italia S.r.l.0 个研究点目标入组 5,000 人开始时间: 2018年10月4日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 5,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- one 至 one（—）
- 性别
- All
入选标准
- •All patients having received a Sorin Group aortic valve device in accordance with the IFU can be included in the registry. Other than the indication and the contra-indications specified in each IFU, there are no specific inclusion and exclusion criteria since this registry has the aim to include all patients following real life”/standard of care practices at participating centers. All patients must provide written or oral informed consent to participate in the registry following the local regulations.
排除标准
- •Any contra indication(s) for valve Implantation.
研究者
相似试验
终止
不适用
Sorin Universal REgistry on Aortic Valve ReplacementAortic Valve DiseaseAortic StenosisNCT02679404Corcym S.r.l2,758
终止
不适用
Transcatheter Aortic Valve Replacement for Pure Severe Aortic Regurgitation, Pilot studyDiseases of the circulatory systemKCT0003085Asan Medical Center2
已完成
不适用
Medtronic PERIcardial SurGical AOrtic Valve ReplacemeNt Pivotal Trial (PERIGON) Long-term Follow-Up. A multi-center, non-randomized trial to determine the safety and effectiveness of the Model 400 aortic valve bioprosthesis in patients with aortic valve disease.Aortic Valve Replacementnew heart valve10046973NL-OMON54842Medtronic B.V.120
招募中
不适用
International Transcatheter Aortic Valve Replacement Registry : Multicenter observational study (Helsinki and Kamakura)aortic stenosisJPRN-UMIN000040413Shonan Kamakura General Hospital4,500
招募中
不适用
Transcatheter Aortic Valve Replacement Registry: 30 day-mortality and it predictorsfor trials without interventiontranscatheter aortic valve replacementaortic stenosisTCTR20200712002/A200